Legend Biotech Corporation (LEGN) saw its stock price surge 5.00% in Monday's trading session, outperforming the broader market. The significant uptick in the company's shares comes as investors react positively to a recent announcement.
The biotech firm revealed plans to host a live webcast for investors on June 1, 2025, during the prestigious American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. This announcement appears to have sparked renewed interest in Legend Biotech's stock, driving the sharp increase in share price.
During the event, Legend Biotech's CEO Ying Huang, Ph.D., and CMO Mythili Koneru, M.D., Ph.D., along with expert clinicians, will present the latest updates from the company's CARTITUDE development program. This program is crucial to Legend Biotech's cell therapy pipeline, and new data could potentially impact the company's future prospects. The anticipation of these updates and the opportunity for investors to gain insights directly from the company's leadership seem to be the primary factors behind today's stock rally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.